Final report on racial profiling allegations ‘to be released soon’
Nearly four years since the investigation into allegations of racial profiling began, the Council for Medical Schemes has indicated that the final report is almost complete.
#CouncilforMedicalSchemes
Another setback for CMS in legal battle over LCBO documents
The signing of the NHI Act does not mean the BHF is letting up in its fight for regulations on low-cost benefit options.
CMS invites BHF to collaborate, criticises ‘forum-shopping’ tactics
The BHF’s canvassing of key policy issues in the public domain via a ‘deliberately leaked’ lawyer’s letter indicates the organisation ‘has run out of creative ideas’.
Council mulls outsourcing appeal adjudication amid BHF accusations
The CMS asserts that medical schemes have frequently disregarded the existing appeals procedures, exploiting them to the detriment of members’ interests.
CMS denies it is sabotaging medical schemes to boost NHI
The regulator comes out swinging in its response to the Board of Healthcare Funders’ claims of bullying and curatorship abuse.
Primary health insurance policies can be sold for another year
The exemption will remain in force for 12 months unless a decision is made on low-cost benefit options before 31 March 2025.
Board of Healthcare Funders takes Council for Medical Schemes to task in lawyer’s letter
The BHF raises 10 issues, including the ‘misuse’ of curatorships, whether NHI is informing policy prematurely, and the absence of low-cost benefit options.
CMS training for new medical scheme trustees
The induction programme takes place online over two days in February.
CMS publishes list of approved medical scheme options for 2024
According to the circular, the regulator has approved the launch of only one new option next year.
What medical schemes paid brokers in 2022
The regulator’s latest Industry Report contains detailed information about the medical schemes industry.
All open medical schemes – except one – have solvency ratios far above the required minimum
And the solvency ratio of the restricted Transmed Medical Fund continued to fall in 2022.
